Despite advances in developing radiopharmaceuticals, manufacturing such drugs remains a challenge. One startup’s plan to tackle the issue is beginning to round into form and, simultaneously, it’s receiving a hearty, cash-rich endorsement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
BECOME A PREMIUM SUBSCRIBER